Phathom Pharmaceuticals's total assets for Q4 2025 were $259.15M, an increase of 7.85% from the previous quarter. PHAT total liabilities were $697.32M for the fiscal quarter, a 5.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.